Nephrol Dial Transplant (2001) 16: 2058-2066
© 2001 European Renal Association-European Dialysis and Transplant Association
Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection
1 Institute of Clinical Pathology, 2 Department of Laboratory Medicine, 3 Department of Internal Medicine III and 4 Institute of Immunology, University of Vienna, Vienna, Austria
Background. Capillary deposition of complement split product C4d has been suggested to be a valuable marker for humoral rejection. In this retrospective study we evaluated the clinical impact of C4d deposition in renal allografts with special emphasis on associations between C4d staining patterns and histological features of acute rejection.
Methods. One hundred and two allograft biopsies obtained from 61 kidney transplants (1–532 days after transplantation; median 14 days) were examined by immunohistochemistry on routine paraffin sections using a novel anti-C4d polyclonal antibody (C4dpAb).
Results. Fourty-two of 102 biopsies showed endothelial C4d deposits in peritubular capillaries (PTC). Histopathological analysis revealed a significantly lower frequency of positive C4d staining in biopsies with rather than in those without acute cellular rejection defined by the Banff grading schema (P<0.01). For clinical evaluation, patients were classified according to C4d staining in allografts (C4dPTC positive in at least one biopsy, n=31 vs C4dPTC negative in all biopsies, n=30). C4dPTC positive patients had significantly higher serum creatinine levels than C4d negative patients. Even in the absence of morphological evidence for rejection, differences in serum creatinine levels between C4dPTC positive and negative recipients were significant (6 months: 2.01±0.75 vs 1.41±0.27 mg/dl; 12 months: 1.95±0.60 vs 1.36± 0.34 mg/dl; 18 months: 1.98±0.50 vs 1.47±0.31 mg/dl; P<0.05). All patients with rejection resistant to conventional therapy (n=4) were in the C4dPTC positive subgroup. All recipients with panel reactive antibodies (PRA) >50% (n=8) were C4dPTC positive.
Conclusions. Our data indicate that endothelial C4d deposition is associated with inferior graft outcome. We provide evidence that this immunohistochemical finding and its clinical impact are not associated with morphological signs of cellular rejection.
Keywords: C4d; complement activation; endothelium; humoral rejection; immunohistochemistry; kidney transplantation
Correspondence and offprint requests to: Dr Georg A. Böhmig, Department of Internal Medicine III, Division of Nephrology and Dialysis, University of Vienna, Währinger Gürtel 18–20, A-1090 Vienna, Austria. Email: georg.boehmig{at}nephro.med3.akh\|[hyphen]\|wien.ac.at
5 H. Regele and M. Exner contributed equally to this work.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Kieran, X. Wang, J. Perkins, C. Davis, E. Kendrick, R. Bakthavatsalam, N. Dunbar, P. Warner, K. Nelson, K. D. Smith, et al. Combination of Peritubular C4d and Transplant Glomerulopathy Predicts Late Renal Allograft Failure J. Am. Soc. Nephrol., October 1, 2009; 20(10): 2260 - 2268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kozakowski, G. A. Bohmig, M. Exner, A. Soleiman, N. Huttary, K. Nagy-Bojarszky, R. C. Ecker, Z. Kikic, and H. Regele Monocytes/macrophages in kidney allograft intimal arteritis: no association with markers of humoral rejection or with inferior outcome Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1979 - 1986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ranjan, R. Nada, V. Jha, V. Sakhuja, and K. Joshi The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1735 - 1741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Jindra, A. Hsueh, L. Hong, D. Gjertson, X.-D. Shen, F. Gao, J. Dang, P. S. Mischel, W. M. Baldwin III, M. C. Fishbein, et al. Anti-MHC Class I Antibody Activation of Proliferation and Survival Signaling in Murine Cardiac Allografts J. Immunol., February 15, 2008; 180(4): 2214 - 2224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Seemayer, A. Gaspert, V. Nickeleit, and M. J. Mihatsch C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques Nephrol. Dial. Transplant., February 1, 2007; 22(2): 568 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Imai, S. Nishi, B. Alchi, M. Ueno, S. Fukase, M. Arakawa, K. Saito, K. Takahashi, and F. Gejyo Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2589 - 2595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Magil and K. J. Tinckam Focal peritubular capillary C4d deposition in acute rejection Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1382 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Racusen and M. Haas Antibody-Mediated Rejection in Renal Allografts: Lessons from Pathology Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 415 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Troxell, L. A. Weintraub, J. P. Higgins, and N. Kambham Comparison of C4d Immunostaining Methods in Renal Allograft Biopsies Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 583 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Tinckam and A. Chandraker Mechanisms and Role of HLA and non-HLA Alloantibodies Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 404 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Hill, E. Gagliardini, P. Ruggenenti, and G. Remuzzi Severe early acute humoral rejection resulting in allograft loss in a renal transplant recipient with Campath-1H induction therapy Nephrol. Dial. Transplant., August 1, 2005; 20(8): 1741 - 1744. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Dragun, D. N. Muller, J. H. Brasen, L. Fritsche, M. Nieminen-Kelha, R. Dechend, U. Kintscher, B. Rudolph, J. Hoebeke, D. Eckert, et al. Angiotensin II Type 1-Receptor Activating Antibodies in Renal-Allograft Rejection N. Engl. J. Med., February 10, 2005; 352(6): 558 - 569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Bakker, K. Koop, Y. W. Sijpkens, M. Eikmans, I. M. Bajema, E. de Heer, J. A. Bruijn, and L. C. Paul Early Interstitial Accumulation of Collagen Type I Discriminates Chronic Rejection from Chronic Cyclosporine Nephrotoxicity J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2142 - 2149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. P. Polack, M. N. Teng, P. L.Collins, G. A. Prince, M. Exner, H. Regele, D. D. Lirman, R. Rabold, S. J. Hoffman, C. L. Karp, et al. A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease J. Exp. Med., September 16, 2002; 196(6): 859 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Regele, G. A. Bohmig, A. Habicht, D. Gollowitzer, M. Schillinger, S. Rockenschaub, B. Watschinger, D. Kerjaschki, and M. Exner Capillary Deposition of Complement Split Product C4d in Renal Allografts is Associated with Basement Membrane Injury in Peritubular and Glomerular Capillaries: A Contribution of Humoral Immunity to Chronic Allograft Rejection J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2371 - 2380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Watschinger and M. Pascual Capillary C4d Deposition as a Marker of Humoral Immunity in Renal Allograft Rejection J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2420 - 2423. [Full Text] [PDF]
|
|
|
|
|
|
M. Haas, G. A. Bohmig, Z. Leko-Mohr, M. Exner, H. Regele, K. Derfler, W. H. Horl, and W. Druml Peri-operative immunoadsorption in sensitized renal transplant recipients Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1503 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Bohmig, M. Exner, A. Habicht, M. Schillinger, U. Lang, J. Kletzmayr, M. D. Saemann, W. H. Horl, B. Watschinger, and H. Regele Capillary C4d Deposition in Kidney Allografts: A Specific Marker of Alloantibody-Dependent Graft Injury J. Am. Soc. Nephrol., April 1, 2002; 13(4): 1091 - 1099. [Abstract] [Full Text] [PDF]
|
|